13C Sodium Octanoate

Investigated by: Hadassah Medical Organization · Henry Ford Health System · Medical University of South Carolina · Meridian Bioscience, Inc. · Northwestern University · Toronto General Hospital

today NCT01433016 · Ph 2

2012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT01433016	Nov 2011 → May 2012	hepatocellular carcinoma	Meridian Bioscience, Inc.	Terminated	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	13C Sodium Octanoate	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01433016 ↗